Need professional-grade analysis? Visit stockanalysis.com
$81.65B
22.69
1,840
N/A
Marksans Pharma Limited (MARKSANS) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at INR179.23, down 0.53% from the previous close.
Over the past year, MARKSANS has traded between a low of INR156.89 and a high of INR214.35. The stock has lost 16.4% over this period. It is currently 16.4% below its 52-week high.
Marksans Pharma Limited has a market capitalization of $81.65B, with a price-to-earnings ratio of 22.69.
Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. Its product portfolio includes plain, enteric-coated, and film coated tablets; soft gelatin and hard capsules; oral liquids; and ointments, as well as creams and liquids. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Side-by-side comparison against top Healthcare peers.